Learning Objectives

Upon completing the module Opportunistic Infections: Prophylaxis, participants should be able to:

  1. List the criteria for initiating prophylaxis for Pneumocystis pneumonia.
  2. Discuss common adverse effects associated with the use of trimethoprim-sulfamethoxazole (Bactrim, Septra) or dapsone.
  3. Identify the ways in which humans can acquire Toxoplasma gondii infection.
  4. Understand the criteria for discontinuing prophylaxis for Toxoplasma encephalitis.
  5. Identify the CD4 cell count range for HIV-infected patients are at risk for developing disseminated Mycobacterium avium complex infection.
  6. Discuss the recommended prophylaxis agents for the prevention of disseminated Mycobacterium avium complex infection.
  7. Describe the criteria used for a positive tuberculin skin test in an HIV-infected person.
  8. Discuss whether anergy testing is recommended for HIV-infected patients.